Nikhil Amin

Dr. Nikhil Amin is responsible for driving Glenmark’s research and development efforts, and also heads the newly formed Innovative Medicines Group that focuses on the discovery and development of novel medicines. Dr. Amin is a Certified Pulmonologist from the American Board of Pediatrics, with over twenty-five years of Academic, Research and Pharmaceutical Industry experience as a Head of R&D and Clinical Development. He is a well-respected faculty within academia and research in the fields of Respiratory (including cystic fibrosis, asthma, COPD, pulmonary hypertension), Metabolism (diabetes mellitus, osteopenia), Inflammation, Pain, and Inhaled Vaccines.

Prior to joining Glenmark, Dr. Amin was the Global Clinical Lead – Inflammation and Immunology at Regeneron Pharmaceuticals Inc. He has also previously held positions of increasing seniority at MannKind Corporation, Paramus, New Jersey as well as academic positions at New York Medical College, Valhalla, New York.

Dr. Amin holds Fellowships in Pediatric Pulmonology and General Academic Pediatrics from the New York Medical College, NY, USA, as well as an M.D. in Pediatrics from The Maharaja Sayajirao University, Baroda, India.